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doi:10.1016/j.jtcvs.2007.07.060bjective: Our objective was to investigate the surgical management of primary
ung cancer by board-certified thoracic surgeons participating in the general thoracic
urgery portion of The Society of Thoracic Surgeons database.
ethods: We identified all pulmonary resections recorded in the general thoracic
urgery prospective database from 1999 to 2006. Among the 49,029 recorded
perations, 9033 pulmonary resections for primary lung cancer were analyzed.
esults: There were 4539 men and 4494 women with a median age of 67 years
range 20–94 years). Comorbidity affected 79% of patients and included hyperten-
ion in 66%, coronary artery disease in 26%, body mass index of 30 kg/m2 or more
n 25.7%, and diabetes mellitus in 13%. The type of resection was a wedge resection
n 1649 (18.1%), segmentectomy in 394 (4.4%), lobectomy in 6042 (67%), bilo-
ectomy in 357 (4.0%), and pneumonectomy in 591 (6.5%). Mediastinal lymph
odes were evaluated in 5879 (65%) patients; via mediastinoscopy in 1928 (21%),
odal dissection 3722 (41%), nodal sampling in 1124 (12.4%), and nodal biopsy in
29 (8%). Median length of stay was 5 days (range 0–277 days). Operative
ortality was 2.5% (179 patients). One or more postoperative events occurred in
911 (32%) patients.
onclusion: The patients in the general thoracic surgery database are elderly, gender
alanced, and afflicted by multiple comorbid conditions. Mediastinal lymph node
valuation is common and the pneumonectomy rate is low. The length of stay is
hort and operative mortality is low, despite frequent postoperative events.
 
he operative mortality of pulmonary resection for lung cancer reporte
several national databases (4%–5%) is substantially higher than that indi-
cated in recent reports from databases that only include operations performed
y dedicated thoracic surgeons (2%).1-3 Although incompletely studied, clinica
raining and board certification are thought to affect outcomes of surgical proce-
ures.4 To further examine this hypothesis, we queried the general thoracic su
ortion of The Society of Thoracic Surgeons (GTS-STS) database to study the
atient population, types of procedures being performed, and short-term outcomes
f patients undergoing pulmonary resection for primary lung cancer by board-
ertified thoracic surgeons.
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G
TSatients and Methods
he Society of Thoracic Surgeons (STS) has maintained a pro-
pective database of patients undergoing cardiothoracic surgery in
he United States since 1987.5 In 1999 the database was expand
o include data for general thoracic surgery operations. Submission
o the database is voluntary and not restricted to members of the
TS. Thus far, 225 surgeons have contributed to the database. The
roup consists of 220 (97%) board-certified thoracic surgeons, 4
1.8%) surgeons who are in a thoracic surgery residency program
ccredited by the Accreditation Council for Graduate Medical
ducation (ACGME), and 1 (0.4%) who is not board certified in
horacic surgery. The institutional review board of each participat-
ng site has approved the use of the database for research.
Data are harvested from participants on a yearly basis, and each
articipant received a quality report and the opportunity to amend
issing or aberrant data. Data submissions are checked for com-
leteness as well as compliance with preset limits on individual
ata fields. Harvested data are maintained and analyzed within the
uke Clinical Research Institute (DCRI) in full compliance with
he Health Insurance Portability and Accountability Act (HIPAA)
f 1996. Variables are collected on a data form that includes
nformation about patient demographics, medical history, surgical
rocedures, cancer staging, and outcome (http://www.ctsnet.o
le/ThoracicDCFV2_07_Nonannotated.pdf).
Between January 1999 and July 2006, a total of 49,029 oper-
tions were entered into the GTS-STS database, including 9077
ulmonary resections for primary lung cancer. Patients without
ata for age, gender, or surgery date were excluded from the
resent study. We also excluded patients with a recorded age of 17
ears or less and more than100 years. These requirements ex-
luded 44 patients; thus 9033 patients were examined. Additional
imits were imposed on individual data fields to exclude analysis of
ighly improbable data. We excluded body mass index data if the
ecorded height was less than 97 cm, forced expiratory volume in
second data if less than 5% of predicted, diffusion capacity of
arbon monoxide data if less than 10% of predicted, and data for
Abbreviations and Acronyms
GTS-STS General Thoracic Surgery portion of The
Society of Thoracic Surgeons database
ACS  American College of Surgeons
ACGME  Accreditation Council for Graduate
Medical Education
AJCC  American Joint Committee on Cancer
ASA  American Society of Anesthesia
CCACS  Commission on Cancer report from the
American College of Surgeons
DCRI  Duke Clinical Research Institute
GTS-STS General Thoracic Surgery portion of The
Society of Thoracic Surgeons database
HIPAA  Health Insurance Portability and
Accountability Act
STS  The Society of Thoracic Surgeons
VATS  video-assisted thoracic surgeryperative time if less than 10 minutes. Missing data were excluded (
48 The Journal of Thoracic and Cardiovascular Surgery ● Febrrom calculations. Postoperative complications occurring during
he same hospitalization as the resection were defined by the STS
atabase guidelines.5 Operative mortality is defined as death d-
ng the same hospitalization for the pulmonary resection or within
0 days of the procedure. Cancer staging was done in accordance
ith the American Joint Committee on Cancer (AJCC).6
For categorical variables, the prevalence was calculated from
he patient records with complete data for each respective variable.
or continuous variables, median values are given with the range.
o estimate the annual lung resection volume among GTS-STS
atabase participants, we averaged the number of lobectomies
one per year for primary lung cancer for each participant.
esults
he median age was 67 years (range 20–94 years). There
ere 4539 (50.2%) men and 4494 (49.8%) women. The
ajority of operations (87.3%) were performed on white
atients; African Americans accounted for 7% of the pa-
ients. Patient characteristics are shown in Table 1.
A smoking history was present in 7645 (87%) patients
nd the median tobacco exposure was 45 pack-years (range
–210 pack-years). Before the operation, 4218 (55%) pa-
ients had stopped smoking for at least 1 year, whereas 2207
28.6%) patients were still smoking within 2 weeks of their
peration (Table 2).
Pulmonary function tests were available on 7344 (84%)
atients. Preoperative forced expiratory volume in 1 second
as available for 6799 (75%) patients and was a median of
8% of predicted (range 14%–200%). Diffusion capacity of
arbon monoxide was recorded in 5455 (60%) patients and
as a median of 70% of predicted (range 12%–169%)
ABLE 1. Characteristics of the patients undergoing pul-
onary resection (n  9033) for bronchogenic carcinoma
ariable: No. of patients with data
% of 9033)
ge: n  9033 (100%) Median 67 y (range 20–94 y)
ender: n  9033 (100%)
Male 4539 (50.2%)
Female 4494 (49.8%)
ace: n  8887 (98.4%)
White 7760 (87.3%)
African American 624 (7%)
Asian 136 (1.5%)
Hispanic 118 (1.3%)
Other 249 (2.8%)
ody mass index: n  8038
(89%)
Median 26.4 (range 15–77)
EV1 predicted: n  6799
(75%)
Median – 77.5% (range 14%–200%)
LCO predicted: n  5455
(60%)
Median – 70% (range 12%–169%)
EV1, Forced expiratory volume in 1 second; DLCO, diffusion capacity of
arbon monoxide.Table 1).
uary 2008
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G
TSAt least one comorbidity was present in 7173 (79%) of
atients. The most prevalent comorbidities were hyperten-
ion (66%) and coronary artery disease (26%) (Table 2
ubrod score of 0 or 1 was present in 92% of patients.
onversely, 70% (5642) of patients were in American So-
iety of Anesthesia (ASA) class III or greater. The median
ABLE 2. Comorbidities (n  9033)
omorbidity: No. of patients with
ata (% of 9033) Affected patients (%)*
ypertension: 6977 (77%) 4571 (66%)
oronary artery disease: 6794
(75%)
1782 (26%)
iabetes mellitus: 8768 (97.1%) 1142 (13%)
eripheral vascular disease:
6749 (74.7%)
767 (11.4%)
erebral vascular event: 8669
(96%)
685 (7.9%)
ongestive heart failure: 6722
(74%)
296 (4.4%)
enal insufficiency: 8901
(98.5%)
217 (2.4%)
reoperative chemotherapy:
6787 (75.1%)
1097 (16%)
reoperative radiotherapy: 6770
(75%)
800 (11.8%)
rior thoracic surgery: 6773
(75%)
1290 (19%)
ody mass index  30: 8038
(89%)
2067 (25.7%)
istory of smoking: 8793 (97.3%) 7645 (87%)
Quit 12 mo before
resection
4218 (54.6%)
Quit between 30 d and 12 mo
before resection
884 (11.4%)
Quit between 14 and 30 d
before resection
417 (5.4%)
Quit 0-14 d before resection 2,207 (28.6%)
ack-years of smoking Median 45 (range 1–210)
ubrod score: 8334 (92%)
0 3598 (43%)
1 4079 (49%)
2 489 (5.9%)
3 136 (1.6%)
4 or 5 32 (0.1%)
SA category: 8117 (90%)
I 208 (2.6%)
II 2,267 (28%)
III 4927 (60.7%)
IV 711 (8.8%)
V 4
SA, American Society of Anesthesiology. *The percentage of patients
ith data for each variable (noted in left column) that are affected by each
omorbidity (noted in right column).ody mass index was 26.4 kg/m2 (range 15- 2 kg/m2); i
The Journal of Thoracic5.7% of patients had a body mass index greater than 30
g/m2.
Preoperative chemotherapy was given to 557 (6.2%)
atients and 373 (4.1%) received preoperative radiotherapy.
rior thoracic surgery had been performed in 1290 (19%),
ut only 293 (4.3%) resections were considered as a reop-
rative procedure (implying that other procedures did not
nvolve the hemithorax of the resection being reported to the
atabase).
The procedure was considered elective in 7971 (93%)
nd urgent or emergency in 610 (7%). The types of proce-
ures are listed in Table 3. Operative time (skin incisi
kin closure) was available for 7833 (87%) patients. The
edian operative time was 152 minutes (range 10-840
inutes) and varied with the type of resection (Tabl
he surgical approach consisted of thoracotomy in 6087
atients (70%), video-assisted thoracic surgery (VATS) in
429 (28%), and others in 230 (2%). Lobectomy was per-
ormed via VATS in 1040 patients or 20% of all lobecto-
ies. Over the past 3 years the percentage of lobectomies
erformed by VATS has increased (21.6% in 2004, 28.6%
n 2005, and 32% in 2006).
The median number of lobectomies for lung cancer per-
ormed per year per participant was 31.4 (range 1–128)
Figure 1). Four (7%) participants performed fewer tha
esections per year, 8 (14%) performed more than 7 but
ewer than 17 resections per year, and 47 (79%) centers
erformed 17 or more resections per year.
Mediastinal lymph nodes were evaluated in 5879 (65%)
atients: via mediastinoscopy in 1928 (21%), nodal dissec-
ion 3722 (41%), nodal sampling in 1124 (12.4%), and
odal biopsy in 729 (8%).
Complete pathologic surgical stage was recorded in 4864
54%) resections and is listed in Table 4. A T stage w
vailable in 7369 (82%): T0 in 61, T1 in 3493, T2 in 2921,
3 in 493, and T4 in 401. An N stage was recorded in 6936
77%): N0 in 5155, N1 in 1020, N2 in 740 (10.7%), and N3
n 21. Of note, 177 of the N2-positive patients received
ABLE 3. Pulmonary resections (n  9033)
ype of resection
No. of patients
(%)*
Median operative
time,
min (range)
neumonectomy 591 (6.5%) 199 (10–700)
ilobectomy 357 (4.0%) 189 (35–499)
obectomy 5,957 (66%) 159 (10–840)
leeve lobectomy 85 (0.9%) 246 (49–548)
egmentectomy 394 (4.4%) 155 (26–379)
ingle wedge resection 1,275 (14%) 90 (10–799)
ultiple wedge resections 374 (4.1%) 90 (20–634)
Percentage of the 9033 resections in the database.nduction chemotherapy, 133 received induction radiother-
and Cardiovascular Surgery ● Volume 135, Number 2 249
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G
TSpy, and 125 received both. M stage was listed for 5022
esections (56%). A total of 188 resections took place in
atients with M1 disease.
At least 1 postoperative complication was recorded in
911 (32%) patients. The most common complications in-
luded atrial arrhythmia necessitating treatment in 964
10.7%), prolonged air leak (7 days) in 722 (8%), pneu-
onia in 351 (3.9%), reintubation in 306 (3.4%), or atelec-
asis in 325 (3.6%) (Table 5). Perioperative blood tran
ion was recorded in 647 (7%) patients. The median length
f stay was 5 days (range 0–277 days).
In-hospital mortality information was available for 8905
98.6%) patients. Overall, 161 (1.8%) patients died in the
ospital after the operation. Thirty-day mortality informa-
ion was available in 7843 patients, and 178 (2.3%) died
ithin 30 days of the operation. Operative mortality was
igure 1. Participant lobectomy volume. The average number of
obectomies for primary lung cancer submitted to the GTS-STS
er year (y-axis) was determined for each of the 59 participants
x-axis). The STS database refers to the registered party as a
participant.” Each participant may therefore consist of a hospi-
al, a surgical department, a group practice, or an individual
urgeon.
ABLE 4. Pathologic surgical stage (n  4864)
AJCC stage No. of patients (%)*
0 16 (0.3%)
IA 1,952 (40.1%)
IB 1,277 (26.2%)
IIA 182 (3.7%)
IIB 498 (10.2%)
IIIA 454 (9.3%)
IIIB 228 (4.7%)
IV 257 (5.3%)
JCC, American Joint Commission on Cancer. *Prevalence among the
catients with complete data for pathologic stage (n  4864).
50 The Journal of Thoracic and Cardiovascular Surgery ● Febr.5% (197/7840). Mortality varied by surgical procedure
Table 6).
iscussion
he patients in the general thoracic portion of the STS
atabase undergoing pulmonary resection for primary lung
ancer are predominately white, evenly split between men
nd women, and commonly affected by comorbid condi-
ions. Previous database studies of surgical resection for
ung cancer have found patients to be of similar age and
thnic background, with similar comorbidities, but to have
hown a stronger male predominance. In the Commission
n Cancer report from the American College of Surgeons
CCACS) about patients who underwent surgical resection
or lung cancer, there were 55% men versus 45% women.
The prevalence and duration of smoking is consistent
ith the patient population with non–small cell lung cancer.
owever, more than a quarter of patients smoked within 2
eeks of their resection. Although continued smoking has
een reported to increase complications after pulmonary
esection, the optimal smoke-free interval remains un-
ABLE 5. Complications
omplication
Affected
patients (%)*
trial arrhythmia requiring treatment 964 (10.7%)
ir leak  5 d 722 (8%)
neumonia 351 (3.9%)
telectasis requiring bronchoscopy 325 (3.6%)
eintubation 306 (3.4%)
ther pulmonary event 319 (3.5%)
rinary tract infection 129 (1.4%)
ew renal failure requiring treatment or
doubling creatinine
125 (1.4%)
dult respiratory distress syndrome 99 (1.1%)
racheostomy 103 (1.1%)
nitial ventilator support  48 h 76 (0.8%)
entricular arrhythmia requiring treatment 71 (0.8%)
leus 72 (0.8%)
epsis 71 (0.8%)
leeding requiring reoperation 66 (0.7%)
ronchopleural fistula 27 (0.3%)
ulmonary embolus 34 (0.4%)
yocardial infarction 37 (0.4%)
eep venous thrombosis requiring treatment 41 (0.5%)
mpyema 29 (0.3%)
ound infection 26 (0.3%)
entral neurologic event 47 (0.5%)
ecurrent laryngeal nerve paresis 20 (0.2%)
hylothorax 50 (0.6%)
elerium tremens 25 (0.3%)
ther 736 (8.1%)
Prevalence within total resection population (n  9033).lear.7,8 Ideally, with database maturation a more complete
uary 2008
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G
TSata analysis will be able to yield an evidence-based rec-
mmendation on whether or not to postpone pulmonary
esection in current smokers.
Lobectomies were the most common type of lung cancer
esection, 20% of which were approached minimally inva-
ively via VATS.9 This high proportion of VATS m
eflect the selective participation in the GTS-STS database.
The current pneumonectomy rate of 6.5% is less than
alf the rate of 13.3% reported by the CCACS st2
lthough patient selection and surgical staging may influ-
nce the pneumonectomy rate, advanced oncologic knowl-
dge allows for tailoring of the appropriate resection and
educes the number of unnecessary pneumonectomies.
Operative volume of the hospital in which resection is
erformed has been demonstrated to be important factor
oward patient outcome.10 In the study by Bach and as-
iates,1 the 30-day mortality for pulmonary resection w
% in centers that performed 14 or fewer thoracic proce-
ures per year whereas it was only 3% in centers that
erformed more than 19 procedures. More recently, Little
nd colleagues2 found the transition in outcomes associat
ith low- and high-volume centers to occur at much higher
ospital volumes. The 30-day mortality rate among hospi-
als performing 90 or fewer resections was 4.8% compared
ith 3.2% among hospitals with more than 90 resections.
irkmeyer and coworkers,11 who reviewed Medicare claim
ata from 1998 to 1999, found adjusted mortality of 6.1%
or institutions that performed fewer than 7 lobectomies per
ear, 5.6% for those that did between 7 and 17, and 5.0% for
hose that did more than 17 per year. Our nonadjusted
0-day mortality of 2.3% and nonadjusted in-hospital mor-
ality of 1.8% are far below these figures; however, in the
urrent study, since participants average 39  28 lobecto-
ies per year, very few participants were in the low-volume
roup.
The prevalence of preresection mediastinoscopy of 21%
n the present study is slightly lower than that of the CCACS
tudy (27%).2 One mechanism to gauge the success 
linical and surgical staging before resection is prevalence
f “unsuspected” N2 disease or the failure to identify N2
ABLE 6. Mortality by resection type
Procedure
In-hospital
mortality
All resections 1.8% (161/890
Lobectomy (including sleeve) 1.4% (86/5957
Bilobectomy 3.4% (12/353)
Pneumonectomy 4.3% (25/586)
Segmentectomy 1.6% (6/384)
Wedge resection 2% (32/1625
Number of reported deaths/number of resections with mortality data.isease before performing a lung resection for cancer. s
The Journal of Thoracicmong two large series of mediastinoscopy performed be-
ore resection, 5% to 8% of patients were found to have
etastasis to N2 nodes that were not identified by medias-
inoscopy.12,13 The rate of pathologic N2 disease in 
urrent study is 740/6936 (10.7%), and 435 of these patients
eceived preoperative therapy. The status of N2 lymph
odes is known to be an important prognostic factor that is
ependent on the extent of mediastinal lymph node evalu-
tion. Although the rate of mediastinal lymph node evalu-
tion in the current study (65% of the operations) is sub-
tantially higher than the rate of 48.1% reported to occur at
ommunity cancer centers by Little and associates,2 N2
tatus was not adequately determined in a considerable
umber of patients.
The stage distribution among patients undergoing resec-
ion in the current study is similar to that reported by the
merican College of Surgeons (ACS) National Cancer Da-
abase during a similar time period.14 In the current repor
6.3% of the patients were in stage I compared with 59.5%
n the ACS study. Mediastinal lymph nodes were evaluated
ess frequently in the ACS study (57.8%) than in our study
65%), raising the possibility that the ACS patients may
ave been understaged. However, with just over half of our
atients staged in accordance with AJCC guidelines, it is
ifficult to make meaningful comparisons to other database
eports. A significant factor contributing to the paucity of
taged patients was the absence of M stage in 3128 resec-
ions. Although the majority of patients were likely to have
0 disease, it was not possible to generate an accurate stage
ithout recorded data.
The median length of stay after pulmonary resection is
ypically reported around 9 days.1,15 The patients in th
resent study had considerably shorter hospital stays (me-
ian 5 days). Although complications certainly prolong the
ength of stay, many other factors, including cultural and
conomic, which are unrelated to the patient’s recovery
rom surgery, can affect the duration of hospitalization.
hus comparison among different database reports is
ifficult.
The majority of patients were highly functional (Zubrod
Thirty-day
mortality
Operative
mortality
2.3% (178/7843) 2.5% (197/7840)
1.8% (93/5242) 2% (101/5234)
3.4% (11/322) 4% (13/322)
5.3% (27/512) 6.2% (32/512)
2.9% (10/347) 2.9% (10/347)
2.6% (37/1425) 2.7% (39/1425)5)*
)
)core of 1 in 92% of patients); however, the ASA classi-
and Cardiovascular Surgery ● Volume 135, Number 2 251
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G
TScation was elevated in the majority, with 70% of patients
aving ASA class III disease or higher. Although ASA class
as not designed to predict anesthesia or operative risk, an
ncreasing ASA class has recently been shown to predict
ortality after pulmonary resection.16 Our database in-
ludes a high percentage of patients with other comorbidi-
ies. Therefore, this patient mix would be expected to have
higher morbidity and mortality than the “average” patient.
Mortality after pulmonary resection has recently been
valuated in several large databases: The National Veterans
ffairs Surgical Quality Improvement Program (3516 pa-
ients), The National Hospital Discharge Survey (512,758
atients), the CCACS 2001 Patient Care Evaluation (11,668
atients), and the Nationwide Inpatient Sample (2118 pa-
ients) (Table 7).1,2,15,17 Among these reports, the 30-d
ortality for all lung resections ranged from 4% to 5.4%,
or lobectomy 4% to 4.5%, and for pneumonectomy 8.5% to
1.5%. All of these values are considerably higher than the
ortality reported in the present study. Several factors at-
ributable to the surgeon and hospital have been shown to
nfluence the perioperative outcome after pulmonary resec-
ion for bronchogenic carcinoma. As previously mentioned,
ospital volume may be an important determinant of out-
ome. The type of hospital (teaching versus private) also
ay influence outcome.18 The training and experience 
he surgeon also are thought to influence operative mortal-
ty. Lung cancer resections by dedicated thoracic surgeons
ave previously been reported to offer advantages over
hose performed by less specialized surgeons.19,20 This find-
ng is consistent with reports in other surgical areas such as
oregut surgery,4 colorectal surgery,21 and vascular sur-
ery,22 where subspecialty training has been shown to -
rease operative mortality and morbidity. The current study
e-emphasizes this fact. The operative mortality for pulmo-
ABLE 7. All databases compared
STS data
(current study)
CCACS survey
(Little et al2)
NIS d
(Mequi
ears 1999–2006 2001 1998–20
ortality defined Hospital or 30-d 30-d Hospital
otal resections 9033 11,668 50,867
ll resections 2.5% (7859) 5.2% (11,668) 3.8%
obectomy 2% (5234) 4.5% (7,869) 3.3%
ilobectomy 4% (322) NA NA
neumonectomy 6.2% (512) 8.5% (1,507) 9.4%
egmentectomy 2.9% (347) NA 3.3%
edge resection 2.7% (1,425) 4.9% (1,737) NA
edian LOS (d) 5
TS, The Society of Thoracic Surgeons; CCACS, Commission on Cancer o
urveillance Epidemiology and End Results; NSQIP, National Veterans Aff
A, not available; LOS, length of stay.ary resections by board-certified thoracic surgeons in the
52 The Journal of Thoracic and Cardiovascular Surgery ● FebrTS-STS database is approximately half that reported by
atabases populated with resections performed by less spe-
ialized surgeons.
This report does have several limitations. Most important
re insufficient data limits and the lack of a formal audit,
hich allow nonsensical data to persist in the database. As
ith all noncompulsory databases, the potential exists for
ncomplete submissions as well as for centers with poor
utcomes to abstain from participating. The STS database
eeds to develop a robust data verification system to reduce
he nonsensical data and ensure completeness. The current
eport is the first from the GTS-STS database and has led to
everal clarifications that ideally will improve the quality
nd quantity of collected data. This does not represent a
ajority of pulmonary resections in the United States. Al-
hough participation in the GTS-STS database has been
ncreasing every year, the data collected for the first 6
onths of 2006 (1646 resections) represent only approxi-
ately 7% of the total resections performed in the United
tates during this time period.
In conclusion, the GTS-STS database is a useful platform
o evaluate the surgical management of lung cancer by
oard-certified thoracic surgeons. The patient demographics
nd comorbid afflictions appear similar to those in larger
eports from national databases. STS surgeons are likely to
valuate mediastinal lymph nodes but less likely to perform
pneumonectomy. The operative mortality is low and
ength of stay is short despite numerous postoperative
vents. Long-term survival of this group of patients awaits
aturation of the database.
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iscussion
r David R. Jones (Charlottesville, Va). I have no conflict of
nterest. I would like to congratulate Dr Boffa and his coauthors on
nicely presented study. Although the GTS-STS database was r
The Journal of Thoracicstablished in 1999, its subsequent acceptance into the general
horacic surgical community has occurred at a surprisingly slow
ace. In fact, as noted by the authors, data included in this study
ikely represent less than 5% to 7% of all pulmonary resections
erformed in the United States. Therefore, this inaugural report
rom Dr Boffa and his colleagues on data harvested from the
atabase is a welcome contribution to the literature. I say this
ecause, finally, board-certified general thoracic surgeons are
racking and now presenting their results, which is in stark contrast
o other databases such as CCACS, the National Hospital Dis-
harge Survey, and others, which include outcomes from non–
oard-certified thoracic surgeons.
Dr Boffa has highlighted the contemporary operation type,
orbidity, and mortality associated with surgical treatment of
rimary lung cancer in the United States today. These results
emonstrate that our morbidities, and specifically our mortality
ates, for resection of primary lung cancer are almost half of those
eported by studies using other databases. These splendid results
ere achieved with a median length of stay of only 5 days and
neumonectomy rates of 6.5%, both far lower than what had
reviously been reported.
I have three questions for the authors. Inasmuch as one of the
rimary charges given the thoracic surgeon is to assure accurate
taging of their patient’s disease before the operation, I was sur-
rised to see that the incidence of preresection mediastinoscopy in
our series was only 21%. Do you have any idea why this number
s so low, and is it possible that it is artificially low owing to the
nherent limitations of such a study as this? Did some patients have
mediastinoscopy at a separate setting perhaps, which may not
ave been captured as a true preresection mediastinoscopy?
Second, inasmuch as several groups have shown that hospital
ase volume may affect overall survival after resection of lung
ancer, how do you think that your results fit into that literature as
e know it today?
Finally, one of the biggest criticisms of any data retrieved from
he GTS-STS database is that there is no mechanism to audit this
elf-reporting data. You mention this in the limitations of your
tudy. What effect do you think this has on your study and what is
eing done to correct this potential bias for those in the audience
ho may wish to join the database?
Dr Boffa. Thank you, Dr Jones. We were a bit surprised by the
ow mediastinoscopy rate. As you suggested, this could be a
henomenon of the database not capturing mediastinoscopy taking
lace before the resection. The STS database is a procedure-
riented database more than a patient-oriented database. As pro-
edures are entered into the database, patient identifiers are ex-
hanged for a unique Duke identifier. Although the mechanism is
uch that the same patient should be given the same Duke identifier
n multiple admissions, it is quite possible that we are missing
ediastinoscopies that were performed preoperatively.
One parameter that has been used to look at the accuracy of
reoperative staging is unsuspected N2 disease. In the current
tudy, 10.4% of patients were found to have N2 disease in their
nal pathology report. Approximately half of the patients with
2-positive disease had received induction therapy. Therefore, the
revalence of unsuspected N2 nodal disease was somewhere be-
ween 5% and 10% (as neoadjuvant may have been given for
easons other than N2 disease). The rate of unsuspected N2 disease
and Cardiovascular Surgery ● Volume 135, Number 2 253
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G
TSs similar to the rate reported from two large series of mediasti-
oscopies by Duke and Washington University in St Louis.
The clinical importance of unsuspected N2 disease is entirely
ependent on the extent of mediastinal lymph node evaluation.
ou never are surprised by a bill if you never check the mailbox.
he STS surgeons evaluated mediastinal lymph nodes in 65% of
esections, which is higher than the rate reported by the American
ollege of Surgeons Commission on Cancer (CCACS) in 2005.
As to the impact on volume, we have generated a curve repre-
enting all the lobectomies in the database distributed over the annual r
54 The Journal of Thoracic and Cardiovascular Surgery ● Febrobectomy volume of the submitting participants. We observed that
he lobectomies were pretty evenly distributed across participants that
verage between 20 and 100 lobectomies per year. Therefore, al-
hough I believe volume is almost certainly a factor, the GTS-STS
atabase represents a wide array of practice volumes.
Finally, the lack of a formal audit is definitely a concern. This
as been discussed at database meetings and the hope is to incor-
orate a formal audit much like the one that is in place in the
ardiac database. Until an audit is implemented, however, this will
emain a valid criticism.
uary 2008
